Menu

Sanofi (SAN:CA) Q3 2026 Earnings Call Transcript
📰

Sanofi (SAN:CA) Q3 2026 Earnings Call Transcript

All Articles on Seeking Alpha·21 days ago
#QKFEEl8G
#seekingalpha#research#sanofi#call#thomas
Long article (317 words) — no AI summary yet.
Reading 0:00
15s threshold

Sanofi ( SAN:CA ) Q3 2026 Earnings Call October 30, 2026 8:30 AM EDT

Company Participants

Thomas Larsen - Head of Investor Relations & General Medicines

Belen Garijo Lopez - CEO & Director

François-Xavier Roger - Executive VP & CFO

Paulo Fontoura - EVP, Global Head of Research & Development (Pharma)

Manuela Buxo - Executive VP & Head of Specialty Care

Conference Call Participants

Matthew Weston - UBS Investment Bank, Research Division

Luisa Hector - Joh. Berenberg, Gossler & Co. KG, Research Division

Sachin Jain - BofA Securities, Research Division

Michael Leuchten - Jefferies LLC, Research Division

Richard Vosser - JPMorgan Chase & Co, Research Division

Peter Verdult - BNP Paribas, Research Division

David Risinger - Leerink Partners LLC, Research Division

James Quigley - Goldman Sachs Group, Inc., Research Division

Florent Cespedes - ODDO BHF Corporate & Markets, Research Division

Graham Glyn Parry - Citigroup Inc., Research Division

Thibault Boutherin - Morgan Stanley, Research…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.